These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36189289)

  • 1.
    Petr V; Csuka D; Hruba P; Szilágyi Á; Kollar M; Slavcev A; Prohászka Z; Viklicky O
    Front Immunol; 2022; 13():985766. PubMed ID: 36189289
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo thrombotic microangiopathy in two kidney transplant recipients from the same deceased donor: A case series.
    Roberts D; Siegman I; Andeen N; Woodland D; Deloughery T; Rueda J; Olyaei A; Rehman S; Norman D; Lockridge J
    Clin Transplant; 2020 Jul; 34(7):e13885. PubMed ID: 32314417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the Incidence and Graft Survival Rate in Kidney Transplant Recipients With
    Hsiung CY; Chen HY; Wang SH; Huang CY
    Transpl Int; 2024; 37():12168. PubMed ID: 38323071
    [No Abstract]   [Full Text] [Related]  

  • 4. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss.
    Petr V; Hruba P; Kollar M; Krejci K; Safranek R; Stepankova S; Dedochova J; Machova J; Zieg J; Slatinska J; Pokorna E; Viklicky O
    Transplant Direct; 2021 Nov; 7(11):e779. PubMed ID: 34712779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo thrombotic microangiopathy after kidney transplantation.
    Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
    Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation.
    Aleš Rigler A; Večerić-Haler Ž; Arnol M; Perše M; Boštjančič E; Pleško J; Simčič S; Kojc N
    J Int Med Res; 2020 Dec; 48(12):300060520980530. PubMed ID: 33372813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
    Fujiyama N; Tasaki M; Harada H; Tsutahara K; Matsumoto A; Kamijo Y; Toyoda M; Iwami D; Inui M; Shirakawa H; Sugimura J; Saito M; Hotta K; Okumi M; Saito K; Watarai Y; Hidaka Y; Ohtani K; Inoue N; Wakamiya N; Habuchi T; Satoh S;
    Clin Exp Nephrol; 2023 Dec; 27(12):1010-1020. PubMed ID: 37634218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and outcomes of
    Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK
    Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early graft loss due to acute thrombotic microangiopathy accompanied by complement gene variants in living-related kidney transplantation: case series report.
    Wu Q; Tian X; Gong N; Zheng J; Liang D; Li X; Lu X; Xue W; Tian P; Wen J
    BMC Nephrol; 2022 Jul; 23(1):249. PubMed ID: 35836191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.
    Le Quintrec M; Lionet A; Kamar N; Karras A; Barbier S; Buchler M; Fakhouri F; Provost F; Fridman WH; Thervet E; Legendre C; Zuber J; Frémeaux-Bacchi V
    Am J Transplant; 2008 Aug; 8(8):1694-701. PubMed ID: 18557729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMA in Kidney Transplantation.
    Imanifard Z; Liguori L; Remuzzi G
    Transplantation; 2023 Nov; 107(11):2329-2340. PubMed ID: 36944606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
    Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
    Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
    Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Thrombotic Microangiopathy in Renal Transplant Patients.
    Özdemir BH; Ok Atılgan A; Yılmaz Akçay E; Özdemir G; Ayvazoğlu Soy E; Akdur A; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):131-135. PubMed ID: 29528010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
    Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
    De Keyzer K; Van Laecke S; Peeters P; Vanholder R
    Am J Nephrol; 2010; 32(5):491-6. PubMed ID: 20975262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.